000			03387nam a22003975i 4500
336			_2rdacontent _aTexto _btxt
337			_2rdamedia _aelectrónico _bc
338			_2rdacarrier _arecurso electrónico _bcr
988			_aSpringer_Medicine_2018
999			_c343850 _d343850 _x1
001			343850
003			ES-MaUEC
005			20230102120148.0
006			a||||fo|||| 00| 0
007			cr nn nnnaamaa
008			180831s2018 gw | s |||| 0|eng d
020			_a9783319933399
024	7		_a10.1007/978-3-319-93339-9 _2doi
040			_aES-MaUEC _bspa _cES-MaUEC
050		4	_aRC280.G4 _b2018 EB
245	1	0	_aGenitourinary Cancers _cedited by Siamak Daneshmand, Kevin G. Chan.
264		1	_aCham, Switzerland _bSpringer International Publishing _c2018
300			_a1 recurso en línea (VI, 308 páginas) _b39 ilustraciones, 38 ilustraciones a color
490	1		_aCancer Treatment and Research, _x0927-3042 ; _v175
490			_aMedicine (Springer-11650)
505	0		_aNew Imaging Techniques in Prostate Cancer -- Targeted ablative therapies for prostate cancer -- Prostate cancer markers -- Prognostic value of CTC's in urologic cancers -- Management of Small Renal Masses -- Advances in the Treatment of Metastatic Renal Cell Carcinoma.-Imaging in urologic cancers -- Molecular prognostication in Bladder cancer -- Early cystectomy for high risk non-muscle invasive disease -- Care-coordination pathway after radical cystectomy -- Current role of checkpoint inhibitors in urologic cancers -- ) The Cancer Genome Atlas Project -- Prognostic models in germ cell tumors -- Modern management of testicular cancer.
520			_aThis book addresses the most pressing current questions in the management of urologic malignancies. Placing the rapid advances in imaging and molecular markers into a clinical context, it explains their effects on prognosis and treatment planning. Similarly, it carefully examines advances in immunotherapy, focusing in particular on the role of immune checkpoint inhibitors in both early- and late-stage urologic malignancies. Looking beyond the improvements in minimally invasive techniques for urologic cancers, it reviews the impacts of care coordination pathways and enhanced recovery after surgery protocols. Futher, the book includes an enlightening discussion of the decision algorithm for the treatment of early-stage, high-grade bladder cancer, taking into account evidence on the most advanced treatment options and the circumstances in which surgery may need to be expedited. The final two chapters are devoted to testicular cancer: the first discusses recent advances in prognostication, while the second elucidates contemporary medical and surgical management.
650		7	_2embne _9172317 _aAparato genital femenino _xCáncer
650		7	_2embne _9189449 _aAparato genital masculino _xEnfermedades
700	1		_aDaneshmand, Siamak. _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt
700	1		_aChan, Kevin G. _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt
776	0	8	_iPrinted edition: _z9783319933382
776	0	8	_iPrinted edition: _z9783319933405
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-319-93339-9 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942			_2lcc _cLE
998			_aSI _a_alco _a_vill _b02/2019 _cm _dz _feng _ggw _h0